Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.
Also called NCT06271577
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 1,000 participants
- Sponsor
- Registry
-
NCT06271577
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06271577. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-12 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
- Acronym
- STLEUISII
- Condition
- Myocardial Infarction
- Condition
- Ischemia
- Condition
- Myocardial Ischemia
- Condition
- Heart Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Vascular Diseases
- Condition
- Heart Attack
- Condition
- Heart Failure
- Intervention (Device)
- AliveCor 12-lead ECG (electrocardiogram)
- Lead sponsor
- AliveCor
Record details
- Record id
cardio:ct-nct06271577- Content hash
b1d21393aa7de6116372d9bc3d18e039dc03411928f5a6ead0ddd38faeca1fc8